Bellevue Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$2.07K | – | 467 |
|
|
2024
Q1 | $2.07K | Sell |
100
-26
| -21% | -$537 | ﹤0.01% | 407 |
|
|
2023
Q4 | $2.91K | Hold |
126
| – | – | ﹤0.01% | 359 |
|
|
2023
Q3 | $1.01K | Hold |
126
| – | – | ﹤0.01% | 449 |
|
|
2023
Q2 | $1.1K | Buy |
+126
| New | +$1.1K | ﹤0.01% | 474 |
|
|
2022
Q2 | – | Sell |
-84
| Closed | -$1K | – | 513 |
|
|
2022
Q1 | $1K | Sell |
84
-20
| -19% | -$238 | ﹤0.01% | 510 |
|
|
2021
Q4 | $1K | Buy |
+104
| New | +$1K | ﹤0.01% | 539 |
|